Cardiac Unloading Alters Contractility and Calcium Homeostasis in Ventricular Myocytes

2000 ◽  
Vol 32 (4) ◽  
pp. 577-584 ◽  
Author(s):  
Michael Ritter ◽  
Zhi Su ◽  
Shixuan Xu ◽  
Jane Shelby ◽  
William H Barry
2020 ◽  
Vol 16 (6) ◽  
pp. e1007572
Author(s):  
David Conesa ◽  
Blas Echebarria ◽  
Angelina Peñaranda ◽  
Inmaculada R. Cantalapiedra ◽  
Yohannes Shiferaw ◽  
...  

1998 ◽  
Vol 274 (4) ◽  
pp. H1308-H1314 ◽  
Author(s):  
Michael A. Laflamme ◽  
Peter L. Becker

We examined the role of β2-adrenergic receptors (ARs) in modulating calcium homeostasis in rat ventricular myocytes. Zinterol (10 μM), an agonist with a 25-fold greater affinity for β2-ARs over β1-ARs, modestly enhanced L-type calcium current ( I Ca) magnitude by ∼30% and modestly accelerated the rate of Ca2+ concentration ([Ca2+]) decline (∼35%) but had little effect on the magnitude of the [Ca2+] transient (a nonsignificant 6% increase). However, 1 μM of the highly selective β1-AR antagonist CGP-20712A completely blocked the I Ca increase induced by 10 μM zinterol. Pretreatment of cells with pertussis toxin (PTX) did not alter I Ca enhancement by 10 μM zinterol, although it did abolish the ability of acetylcholine to block the forskolin-induced enhancement of I Ca. Zinterol (10 μM) approximately doubled adenosine 3′,5′-cyclic monophosphate (cAMP) accumulation, although one-half of this increase was blocked by CGP-20712A. In contrast, 1 μM of the nonselective β-agonist isoproterenol increased cAMP production 15-fold. Thus we found no evidence that activation of β2-ARs modulates calcium homeostasis in rat ventricular myocytes, even after treatment with PTX.


2016 ◽  
Vol 5 (2) ◽  
pp. 682-688 ◽  
Author(s):  
Jing-yi Zhang ◽  
Gui-bo Sun ◽  
Min Wang ◽  
Ping Liao ◽  
Yu-yang Du ◽  
...  

Arsenic trioxide (ATO) is a potent anticancer drug agent but its clinical use is often limited by severe cardiotoxicity.


2019 ◽  
Author(s):  
David Conesa ◽  
Blas Echebarria ◽  
Angelina Peñaranda ◽  
Inmaculada R. Cantalapiedra ◽  
Yohannes Shiferaw ◽  
...  

AbstractVentricular contraction is roughly proportional to the amount of calcium released from the Sarcoplasmic Reticulum (SR) during systole. While it is rather straightforward to measure calcium levels and contractibility under different physiological condition, the complexity of calcium handling during systole and diastole has made the prediction of its release at steady state impossible. Here we approach the problem analyzing the evolution of intracellular and extracellular calcium fluxes during a single beat which is away from homeostatic balance. Using an in-silico subcellular model of rabbit ventricular myocyte, we show that the high dimensional nonlinear problem of finding the steady state can be reduced to a two-variable general equilibrium condition where pre-systolic calcium level in the cytosol and in the SR must fulfill simultaneously two different equalities. This renders calcium homeostasis as a problem that can be studied in terms of its equilibrium structure, leading to precise predictions of steady state from single-beat measurements. We show how changes in ionic channels modify the general equilibrium as shocks would do in general equilibrium macroeconomic models. This allows us to predict when an enhanced entrance of calcium in the cell reduces its contractibility and explain why SERCA gene therapy, a change in calcium handling to treat heart failure, might fail to improve contraction even when it successfully increases SERCA expression.Author summaryCardiomyocytes, upon voltage excitation, release calcium, which leads to cell contraction. However, under some pathological conditions, calcium handling is impaired. Recently, SERCA gene therapy, whose aim is to improve Ca2+ sequestration by the Sarcoplasmic Reticulum (SR), has failed to improve the prognosis of patients with Heart Failure. This, together with recent counterintuitive results in calcium handling, has highlighted the need for a framework to understand calcium homeostasis across species and pathologies. We show here that the proper framework is a general equilibrium approach of two independent variables. The development of this framework allows us to find a possible mechanism for the failure of SERCA gene therapy even when it manages to increase Ca SERCA expression.


Sign in / Sign up

Export Citation Format

Share Document